BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10365217)

  • 1. [Patient information and follow-up of transfusions: "a checked report"?].
    Jullian H; Fuentes AM; Colavolpe JC; Gentille S
    Ann Fr Anesth Reanim; 1999 Apr; 18(4):fi60-3. PubMed ID: 10365217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Can virus safety of blood products be assured?].
    Krusius T
    Duodecim; 1994; 110(13):1227-30. PubMed ID: 7497931
    [No Abstract]   [Full Text] [Related]  

  • 3. [Transfusions of blood and blood products and virus infections].
    Wróblewska M; Piotrowska E; ĺuczak M
    Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When, why and how to order blood?
    Steenssens L
    Acta Anaesthesiol Belg; 2003; 54(4):313-4. PubMed ID: 14719351
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonatal transfusions.
    New HV; Stanworth SJ; Engelfriet CP; Reesink HW; McQuilten ZK; Savoia HF; Wood EM; Olyntho S; Trigo F; Wendel S; Lin Y; Hume H; Petäjä J; Krusius T; Villa S; Ghirardello S; von Lindern J; Brand A; Hendrickson JE; Josephson CD; Strauss RG; Luban NL; Paul W
    Vox Sang; 2009 Jan; 96(1):62-85. PubMed ID: 19121200
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood transfusion safety].
    Koistinen J
    Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion medicine--Scandinavian recommendations].
    Jørgensen J; Jensson O; Eklund J; Kornstad L; Messeter L
    Nord Med; 1994; 109(2):61-3. PubMed ID: 8121792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
    Wagner SJ; Friedman LI; Dodd RY
    Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transfusion of blood and blood derivatives. Measurements of safety, circulatory, immunologic and infectious risks and accidents].
    Rouger P; Hergon E
    Rev Prat; 1997 Sep; 47(13):1499-504. PubMed ID: 9339033
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial contamination of blood products.
    Palavecino E; Jacobs M; Yomtovian R
    Curr Hematol Rep; 2004 Nov; 3(6):450-5. PubMed ID: 15496280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):584. PubMed ID: 23529604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment. Explanation to comment].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):585-9. PubMed ID: 23529605
    [No Abstract]   [Full Text] [Related]  

  • 14. [The responsibility of the physician prescriber of blood products].
    Hergon E; Quaranta JF; Moutel G; Hervé C; Rouger P
    Transfus Clin Biol; 2004 Oct; 11(4):221-7. PubMed ID: 15564105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ways to improve the transfusion support of surgical hospitals under current conditions].
    Danil'chenko VV; Popov SD; Chechetkin AV; Sidorkevich SV; Lazarenko MI
    Vestn Khir Im I I Grek; 1996; 155(4):67-9. PubMed ID: 8992727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B; Arrabal S
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of transfusion means and protocols of massive transfusions].
    Zhiburt EB; Vergopulo AA; Kopchenko TG; Gubanova MN
    Vestn Khir Im I I Grek; 2009; 168(2):75-7. PubMed ID: 19514398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of the use of blood and blood components among South African anaesthetists working in teaching hospitals.
    Irving G
    S Afr Med J; 1992 Nov; 82(5):324-8. PubMed ID: 1448712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond HIV, HBV and HCV--how to deal with other viruses?
    Minor PD
    Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.